Although AFP-L3 alone is effective in detecting early-stage HCC with AFP+ tumors, with 9–12 months of lead time, compared with imaging techniques,26 AFP-L3 is usually not detected when AFP levels are <20 ng/ml. Here, AFP is linked to hepatocellular carcinoma.